Seeing Is Believing
Currently out of the existing stock ratings of Ed Arce, 360 are a BUY (83.33%), 68 are a HOLD (15.74%), 4 are a SELL (0.93%).
Analyst Ed Arce, currently employed carries an average stock price target met ratio of 31.48% that have a potential upside of 29.41% achieved within 168 days. Previously, Ed Arce worked at HC WAINWRIGHT.
Ed Arce’s has documented 879 price targets and ratings displayed on 41 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ARCT, Arcturus Therapeutics Holdings at 17-Dec-2024.
Analyst best performing recommendations are on TERN (TERNS PHARMACEUTICALS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 3/4/2020. The price target of $18 was fulfilled within 1 day with a profit of $1.22 (7.27%) receiving and performance score of 72.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$13
$9.2 (242.11%)
$13
2 months 13 days ago
(11-Oct-2024)
0/15 (0%)
$6.94 (114.52%)
Which stock is Ed Arce is most bullish on?
Which stock is Ed Arce is most reserved on?
What Year was the first public recommendation made by Ed Arce?